Mariner
AMIX

Mariner’s Autonomix Medical AMIX Stock Holding History

Mariner’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
50,138
+47,618
+1,890% +$372K ﹤0.01% 3468
2026
Q1 		$25.9K Sell
2,520
-11
-0.4% -$99 ﹤0.01% 3477
2025
Q4 		$26.5K Sell
2,531
-2,262
-47% -$43.9K ﹤0.01% 3465
2025
Q3 		$50.2K Hold
4,793
– – ﹤0.01% 3445
2025
Q2 		$50.5K Hold
4,793
– – ﹤0.01% 3349
2025
Q1 		$50.6K Buy
4,793
+2
+0% +$111 ﹤0.01% 3312
2024
Q4 		$51.8K Buy
4,791
+4,523
+1,688% +$799K ﹤0.01% 3285
2024
Q3 		$67.4K Buy
+268
New +$90K ﹤0.01% 3153

Other funds holding AMIX

APW
Allied Private Wealth Boca Raton, Florida $156M AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
NA
Networth Advisors Canonsburg, Pennsylvania $172M AUM

Mariner's AMIX Position: Q2 2026 in Review

Mariner increased its Autonomix Medical (AMIX) stake by 1,890% in Q2 2026, buying an estimated $372K and bringing the position to 50,138 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3468.

Mariner first reported a position in AMIX in Q3 2024 and has held it in 8 quarters since. The position peaked at $67.4K in Q3 2024. 6 funds tracked by Wall St. Rank hold AMIX as of Q2 2026.

  • Mariner held 50,138 shares of Autonomix Medical worth $25.6K as of Q2 2026.
  • Mariner bought 47,618 Autonomix Medical shares in Q2 2026, an estimated $372K.
  • Autonomix Medical made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3468 holding.
  • Mariner first reported a position in Autonomix Medical in Q3 2024 and has held it in 8 quarters since.
  • Mariner's Autonomix Medical position peaked at $67.4K in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.